Trial Profile
A phase IIA, randomised, double-blind, double-dummy, placebo and active comparator controlled, 5-way crossover clinical trial to assess the activity, safety, tolerability and pharmacokinetics of single doses of LAS 100977 administered by inhalation to asthma patients.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 05 Sep 2023
Price :
$35
*
At a glance
- Drugs Abediterol (Primary) ; Salmeterol
- Indications Asthma
- Focus Therapeutic Use
- Sponsors Almirall S.A.
- 02 Jun 2012 Actual end date (19 Feb 2008) added as reported by European Clinical Trials Database.
- 01 May 2012 Official title amended as reported by European Clinical Trials Database.
- 01 May 2012 New source identified and integrated (European Clinical Trials Database: EudraCT2007-003415-31).